157 related articles for article (PubMed ID: 24588751)
1. P2Y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting.
Yu PJ; Cassiere HA; Dellis SL; Manetta F; Stein J; Hartman AR
J Card Surg; 2014 May; 29(3):312-6. PubMed ID: 24588751
[TBL] [Abstract][Full Text] [Related]
2. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study.
Reed GW; Kumar A; Guo J; Aranki S; Shekar P; Agnihotri A; Maree AO; McLean DS; Rosenfield K; Cannon CP
Clin Cardiol; 2015 Feb; 38(2):92-8. PubMed ID: 25655085
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
Firstenberg MS; Dyke CM; Angiolillo DJ; Ramaiahm C; Price M; Brtko M; Welsby I; Chandna H; Holmes DR; Voeltz M; Tummala P; Hutyra M; Manoukian SV; Prats J; Todd M; Liu T; Chronos N; Dietrich M; Montalescot G; Cannon LA; Topo EJ
Heart Surg Forum; 2013 Apr; 16(2):E60-9. PubMed ID: 23625478
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing of clopidogrel discontinuation in Japanese patients: platelet aggregation test using the VerifyNow® system.
Takiuchi H; Tanemoto K
Gen Thorac Cardiovasc Surg; 2015 Nov; 63(11):601-6. PubMed ID: 26298730
[TBL] [Abstract][Full Text] [Related]
6. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
[TBL] [Abstract][Full Text] [Related]
7. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
[TBL] [Abstract][Full Text] [Related]
8. P2Y12 platelet function assay as a key predictor for bleeding risk in coronary artery bypass grafting.
Chen ZW; Tao H; Shi KH
J Card Surg; 2014 Nov; 29(6):808. PubMed ID: 24943292
[No Abstract] [Full Text] [Related]
9. Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.
Reichert MG; Robinson AH; Travis JA; Hammon JW; Kon ND; Kincaid EH
Pharmacotherapy; 2008 Feb; 28(2):151-5. PubMed ID: 18225962
[TBL] [Abstract][Full Text] [Related]
10. The role of point-of-care assessment of platelet function in predicting postoperative bleeding and transfusion requirements after coronary artery bypass grafting.
Mishra PK; Thekkudan J; Sahajanandan R; Gravenor M; Lakshmanan S; Fayaz KM; Luckraz H
Ann Card Anaesth; 2015; 18(1):45-51. PubMed ID: 25566711
[TBL] [Abstract][Full Text] [Related]
11. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery.
Kang W; Theman TE; Reed JF; Stoltzfus J; Weger N
J Surg Educ; 2007; 64(2):88-92. PubMed ID: 17462208
[TBL] [Abstract][Full Text] [Related]
12. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study.
Mahla E; Suarez TA; Bliden KP; Rehak P; Metzler H; Sequeira AJ; Cho P; Sell J; Fan J; Antonino MJ; Tantry US; Gurbel PA
Circ Cardiovasc Interv; 2012 Apr; 5(2):261-9. PubMed ID: 22396581
[TBL] [Abstract][Full Text] [Related]
13. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery.
Maltais S; Perrault LP; Do QB
Eur J Cardiothorac Surg; 2008 Jul; 34(1):127-31. PubMed ID: 18455412
[TBL] [Abstract][Full Text] [Related]
14. Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
Mahla E; Tantry US; Prüller F; Gurbel PA
Circulation; 2018 Nov; 138(19):2145-2159. PubMed ID: 30474416
[TBL] [Abstract][Full Text] [Related]
15. Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery.
Ranucci M; Colella D; Baryshnikova E; Di Dedda U;
Br J Anaesth; 2014 Dec; 113(6):970-6. PubMed ID: 25209096
[TBL] [Abstract][Full Text] [Related]
16. Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels.
Voisin S; Bongard V; Tidjane MA; Lhermusier T; Carrié D; Sié P
Thromb Haemost; 2011 Aug; 106(2):227-9. PubMed ID: 21544318
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements.
Filsoufi F; Rahmanian PB; Castillo JG; Kahn RA; Fischer G; Adams DH
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):60-6. PubMed ID: 18249332
[TBL] [Abstract][Full Text] [Related]
18. Platelet function testing to time surgery in patients on dual antiplatelet therapy?
Mahla E; Raggam R; Toller W
Hamostaseologie; 2014; 34(1):40-5. PubMed ID: 24071994
[TBL] [Abstract][Full Text] [Related]
19. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
